Classification of breast cancers, based on immunohistochemical techniques, involves the expression of the following hormone receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene ERBB2 and breast carcinoma.